TECH vs TRT · P/E 65, rev $1.22B vs P/E 294, $148.7M cap
Bio-Techne Corp (TECH) versus Trio-Tech International (TRT) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Trio-Tech International (TRT) is a semiconductor equipment & materials company listed on AMEX.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
TRT does not have a complete income-statement cache yet.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TRT currently screens at market cap $148.7M and trailing P/E 294.0.
Not investment advice. Open the TECH and TRT stock pages for the full models.
Not investment advice.